Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Merck Sharp & Dohme LLC
With
Participants were randomized on Day 1 to the following arms: * 5 mg ERTU and placebo to 15 mg ERTU (5 mg Ertugliflozin) * placebo to 5 mg ERTU and placebo to 15 mg ERTU (Placebo) At Week 12, participants who met the up-titration criteria were re-randomized to the following arms for Weeks 12 to 54: * 5 mg ERTU and placebo to 15 mg ERTU (5 mg/5 mg Ertugliflozin) * 15 mg ERTU and placebo to 5 mg ERTU (5 mg/15 mg Ertugliflozin) Participants who did not meet the up-titration criteria remained on 5 mg ERTU and placebo to 15 mg ERTU from Week 12 to Week 54. The placebo arm continued receiving placebo from Week 12 to Week 54.
Age
10–17
Sex
ALL
Healthy volunteers
Not accepted